Sanofi Genzyme
http://www.genzyme.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sanofi Genzyme
Finance Watch: VC Enthusiasm For Biopharma Continues As 5AM Ventures Raises $750m
Private Company Edition: 5AM revealed two funds totaling $450m and $300m, V-Bio raised a €110m venture capital fund and AXA IM Alts committed $500m for health care private equity deals. Also, TRIANA launched with $110m and the AMR Action Fund backs Adaptive Phage Therapeutics.
COVID-19 Factor Wanes But Pharma’s R&D Pipeline Hits Record Heights
Pharma’s R&D engine has been firing on all cylinders in the past year – pipeline growth in 2021 stood at nearly twice that for the previous year, pushing the number of products under active development over 20,000 for the first time.
AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19
The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.
Celltrion Celebrates Brazilian Tender Win For Infliximab
Celltrion’s Remsima infliximab biosimilar has won a Brazilian federal tender as well as several individual state bids, following earlier awards for the Korean firm’s Truxima (rituximab) and Herzuma (trastuzumab) biosimilars.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- AnorMED
- Bioenvision
- ILEX Oncology, Inc.
- Sangstat Medical Corporation
- Genzyme Corporation